Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

ARTILLERY · Artificial Intelligence for early detection of non-communicable disease risk in people with breast cancer

HORIZONStatus: SIGNED1 May 202330 April 2028EU funding €5,704,756Call HORIZON-HLTH-2022-STAYHLTH-01-two-stage

The ultimate ambition of the ARTILLERY consortium is to enhance long term health of the growing population of breast cancer survivors by making optimal use of routine imaging for timely detection of actionable chronic conditions or their risk factors. ARTILLERY will develop trustworthy AI systems that allow robust and accurate risk prediction of common chronic conditions, including cardiovascular disease, chronic obstructive pulmonary disease, unfavorable body composition and osteoporosis. Implementation of these AI systems in routine care will provide healthcare professionals with objective and quantitative parameters of their patients’ individual chronic disease risks, permitting them to start prompt treatment and implement risk reducing strategies.Unique aspects of ARTILLERY include the continuous and close interaction between renowned computational scientists, influential breast cancer professionals and the largest breast cancer patient advocacy organisation in Europe, as well as direct access to a large and comprehensive Real-World Data infrastructure that includes CT scans and clinical data from >26.000 patients with breast cancer. This partnership will result in trustworthy AI systems for prevalent chronic conditions, relevant to breast cancer patients and physicians, and ready for implementation at radiotherapy workstations across Europe. ARTILLERY-manuals will be developed and made available to multidisciplinary tumour boards and will contain recommendations on how and when (not) to use AI systems in routine breast cancer care, and on optimal management of breast cancer patients identified to be at high risk of chronic conditions.At the end of the project, we will have augmented the understanding and perception of the public towards the use of AI systems in routine healthcare and empowered breast cancer patients to make targeted lifestyle changes based on their individual risk profile, thus improving their life expectancy and quality of life.

Consortium · 11 organisations

coordinator

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL · €1,630,928

participant

REGION HOVEDSTADEN

DK · €703,289

participant

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

DE · €911,560

participant

QUANTIB BV

NL · €255,000

thirdParty

KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN

DE

participant

EUROPA DONNA SLOVENSKO ZDRUZENJE ZA BOJ PROTI RAKU DOJK

SI · €104,688

participant

KOBENHAVNS UNIVERSITET

DK · €341,941

participant

INTELITEH INTELIGENTNE TEHNOLOGIJE D.O.O.

SI · €124,563

participant

STICHTING AMSTERDAM UMC

NL · €994,703

participant

UNIVERZA V LJUBLJANI

SI · €347,798

participant

FUNDACAO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD

PT · €290,289

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.